Furthermore, the gene therapy-based branch-PCR-assembled PTEN gene nanovector (NP-PTEN) approach has been explored to overexpress PTEN protein expression and restore its functions via inhibiting the activation of the PI3K/AKT/mTOR pathway in NSCLC cells [74]. This evidence concerns the gene MTOR and non-small cell lung carcinoma.